当前位置: X-MOL 学术Blood Cancer J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Blood Cancer Journal ( IF 12.8 ) Pub Date : 2022-04-22 , DOI: 10.1038/s41408-022-00651-3
Patrick Harrington 1, 2 , Katie J Doores 3 , Jamie Saunders 1 , Marc de Lord 4 , Chandan Saha 1 , Thomas Lechmere 3 , Hataf Khan 3 , Ho Pui Jeff Lam 1 , Amy O' Reilly 1 , Claire Woodley 1 , Susan Asirvatham 1 , Richard Dillon 1, 5 , Natalia Curto-Garcia 1 , Jennifer O' Sullivan 1 , Shahram Kordasti 1, 2 , Kavita Raj 1 , Michael H Malim 3 , Deepti Radia 1 , Donal McLornan 1, 2 , Claire Harrison 1, 2 , Hugues de Lavallade 1, 2
Affiliation  



中文翻译:

用鲁索替尼治疗的慢性骨髓增生性肿瘤患者对 SARS-CoV-2 疫苗接种的体液和 T 细胞反应受损。

更新日期:2022-04-22
down
wechat
bug